Microbiome-Based Cancer Dx Emerges From Cancer Genome Atlas Reanalysis
NEW YORK – Researchers led by the University of California, San Diego’s Rob Knight have discovered unique microbial DNA signatures in the tissue and blood of cancer patients, leading to the development of a microbiome-based oncology diagnostic tool.